4D Molecular Therapeutics Inc (FDMT) Insider Trading
- $13,600,000.00
- $19,766,144.34
- Sept. 16, 2024
- Scott Bizily
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 16, 2024 | Insider | 500 | $16.33 | Sell | $8,165.00 | |
| July 16, 2024 | Insider | 1,750 | $27.11 | Sell | $47,442.50 | |
| July 11, 2024 | Insider | 1,996 | $25.00 | Sell | $49,900.00 | |
| July 10, 2024 | CEO | 12,923 | $22.49 | Sell | $290,638.27 | |
| July 1, 2024 | Insider | 4,248 | $21.36 | Sell | $90,737.28 | |
| June 24, 2024 | CEO | 12,930 | $23.10 | Sell | $298,683.00 | |
| May 16, 2024 | Insider | 1,750 | $25.45 | Sell | $44,537.50 | |
| April 16, 2024 | Insider | 1,750 | $25.74 | Sell | $45,045.00 | |
| April 1, 2024 | Insider | 8,153 | $31.78 | Sell | $259,102.34 | |
| March 27, 2024 | Insider | 5,833 | $35.04 | Sell | $204,388.32 | |
| March 18, 2024 | Insider | 1,750 | $31.27 | Sell | $54,722.50 | |
| Feb. 27, 2024 | Insider | 1,909 | $30.00 | Sell | $57,270.00 | |
| Feb. 16, 2024 | Insider | 1,750 | $27.67 | Sell | $48,422.50 | |
| Feb. 8, 2024 | Insider | 6,244 | $27.50 | Sell | $171,710.00 | |
| Feb. 8, 2024 | CEO | 92,001 | $27.13 | Sell | $2,495,987.13 | |
| Feb. 5, 2024 | Insider | 24,552 | $30.05 | Sell | $737,787.60 | |
| Jan. 23, 2024 | CEO | 5,696 | $18.41 | Sell | $104,863.36 | |
| Jan. 4, 2024 | CEO | 40,732 | $20.31 | Sell | $827,266.92 | |
| Jan. 4, 2024 | Major Shareholder | 540,000 | $19.53 | Sell | $10,546,200.00 | |
| June 8, 2023 | Insider | 3,750 | $20.85 | Sell | $78,187.50 | |
| June 1, 2023 | Insider | 2,247 | $18.31 | Sell | $41,142.57 | |
| May 9, 2023 | Major Shareholder | 850,000 | $16.00 | Buy | $13,600,000.00 | |
| April 21, 2023 | Director | 5,000 | $20.05 | Sell | $100,250.00 | |
| April 21, 2023 | Insider | 3,750 | $20.00 | Sell | $75,000.00 | |
| March 1, 2023 | Insider | 2,248 | $19.30 | Sell | $43,386.40 | |
| Feb. 21, 2023 | CEO | 17,997 | $20.96 | Sell | $377,217.12 | |
| Jan. 19, 2023 | CEO | 10,899 | $20.03 | Sell | $218,306.97 | |
| Dec. 15, 2022 | CEO | 32,933 | $23.59 | Sell | $776,889.47 | |
| Dec. 1, 2022 | Insider | 6,000 | $22.79 | Sell | $136,740.00 | |
| Oct. 22, 2021 | Director | 1,900 | $31.00 | Sell | $58,900.00 | |
| Oct. 20, 2021 | Director | 11,565 | $31.02 | Sell | $358,746.30 | |
| Sept. 29, 2021 | Director | 16,871 | $28.61 | Sell | $482,679.31 | |
| Sept. 27, 2021 | Director | 19,332 | $32.89 | Sell | $635,829.48 |
Insiders are both buying and selling 4D Molecular Therapeutics Inc stock.
The insider traders at 4D Molecular Therapeutics Inc are: Scott Bizily, David Kirn, David Schaffer, Global Investors Lp Viking, Jacob Chacko, and Robert Young Kim
The most active insider trader at 4D Molecular Therapeutics Inc is Scott Bizily with 17 trades.
Global Investors Lp Viking has sold the most 4D Molecular Therapeutics Inc stock with a total value of $21,092,400.00.
Global Investors Lp Viking has bought the most 4D Molecular Therapeutics Inc stock with a total value of $27,200,000.00.
The most recent insider trade for 4D Molecular Therapeutics Inc was on Sept. 16, 2024.
The single biggest insider buy for 4D Molecular Therapeutics Inc was from Global Investors Lp Viking with a total value of $13,600,000.00 on May 9, 2023.
The single biggest insider sell for 4D Molecular Therapeutics Inc was from Global Investors Lp Viking with a total value of $10,546,200.00 on Jan. 4, 2024.